Therapy-related acute lymphoblastic leukemia with t(8;14)(q11;32) but not 11q23 abnormality

Leukemia and Lymphoma

Volumn 50, Issue 2, 2009, Pages 279-281

  Chen, Wei ^a,b   Huang, Qin ^a  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^b The Affiliated Sir Run Run Hospital of Nanjing Medical University   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CARBOPLATIN; CD34 ANTIGEN; CHLORMETHINE; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; CYTARABINE; DACARBAZINE; DOXORUBICIN; ETOPOSIDE; IFOSFAMIDE; METHOTREXATE; PREDNISONE; PROCARBAZINE; TRANSCRIPTION FACTOR PAX5; VINBLASTINE; VINCRISTINE SULFATE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; ARTICLE; BONE MARROW BIOPSY; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RELAPSE; CASE REPORT; CHROMOSOME 11Q; CHROMOSOME ABERRATION; CHROMOSOME TRANSLOCATION; DECREASED APPETITE; DIZZINESS; DRUG EFFICACY; DRUG FEVER; DRUG INDUCED HEADACHE; DRUG SAFETY; HEMOGLOBIN BLOOD LEVEL; HODGKIN DISEASE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KARYOTYPE; LEUKOCYTE COUNT; MALAISE; MALE; MULTIPLE CYCLE TREATMENT; PRIORITY JOURNAL; SALVAGE THERAPY; STEM CELL TRANSPLANTATION; THROMBOCYTE COUNT;

ADULT; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 14; CHROMOSOMES, HUMAN, PAIR 8; HUMANS; MALE; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA;

EID: 61349189818     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.1080/10428190802652000     Document Type: Article

References (13)

1. Kardon, N. B., Slepowitz, G. and Kochen, J. A. (1982) Childhood acute lymphoblastic leukemia associated with an unusual 8;14 translocation. Cancer Genet Cytogenet, 6, pp. 339-343.
2. Murphy, S. B., Bowman, W. P., Abromowitch, M., Mirro, J., Ochs, J. Rivera, G. et al. (1986) Results of treatment of advanced-stage Burkitt's lymphoma and B cell (SIg+) acute lymphoblastic leukemia with high-dose fractionated cyclophosphamide and coordinated high-dose methotrexate and cytarabine. J Clin Oncol, 4, pp. 1732-1739.
3. Moore, S., Suttle, J., Bain, S., Story, C. and Rice, M. (2003) Acute lymphoblastic leukemia characterized by t(8;14)(q11.2;q32). Cancer Genet Cytogenet, 141, pp. 1-4.
4. Quilichini, B., Zattara, H., Casalonga, F., Bastide-Alliez, L. A., Curtillet, C. Fossat, C. et al. (2003) A new case of t(8;14)(q11;q32) in an acute lymphoblastic leukemia. Atlas Genet Cytogenet Oncol Haematol
5. Balicek, P., Abasova, J. and Hak, J. (2001) A case of Down syndrome with acute lymphoblastic leukemia and t(8;14)(q11;q32). Atlas Genet Cytogenet Oncol Haematol
6. Akasaka, T., Balasas, T., Russell, L. J., Sugimoto, K. J., Majid, A. Walewska, R. et al. (2007) Five members of the CEBP transcription factor family are targeted by recurrent IGH translocations in B-cell precursor acute lymphoblastic leukemia (BCP-ALL). Blood, 109, pp. 3451-3461.
7. Kerndrup, G. B. and Rosthøj, S. (2001) A case of pre-B ALL with t(8;14)(q11;q32). Atlas Genet Cytogenet Oncol Haematol
8. Kaleem, Z., Shuster, J. J., Carroll, A. J., Borowitz, M. J., Pullen, D. J. Camitta, B. M. et al. (2000) Acute lymphoblastic leukemia with an unusual t(8;14)(q11.2;q32): A Pediatric Oncology Group Study. Leukemia, 14, pp. 238-240.
9. Secker-Walker, L. M., Hawkins, J. M., Prentice, H. G., Mackie, P. H., Heerema, N. A. and Provisor, A. J. (1993) Two Down syndrome patients with an acquired translocation, t(8;14)(q11;q32), in early B-lineage acute lymphoblastic leukemia. Cancer Genet Cytogenet, 70, pp. 148-150.
10. Bruning, R. D., Matutes, E., Flandrin, G. and Vardiman, J. (2001) Acute myeloid leukaemias and myelodysplastic syndromes, therapy related. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues, pp. 89-91. IARC, Lyon
11. Shivakumar, R., Tan, W., Wilding, G. E., Wang, E. S. and Wetzler, M. (2008) Biologic features and treatment outcome of secondary acute lymphoblastic leukemia - a review of 101 cases. Ann Oncol, 19, pp. 1634-1638.
12. Tenen, D. G. (2003) Disruption of differentiation in human cancer: AML shows the way. Nat Rev Cancer, 3, pp. 89-101.
13. Helbling, D., Mueller, B. U., Timchenko, N. A., Hagemeijer, A., Jotterand, M. Meyer-Monard, S. et al. (2004) The leukemic fusion gene AML1-MDS1-EVI1 suppresses CEBPA in acute myeloid leukemia by activation of Calreticulin. Proc Natl Acad Sci USA, 101, pp. 13312-13317.